Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACRV | ALDX | PYXS | ||
| Company | Acrivon Therapeutics Inc | Aldeyra Therapeu | Pyxis Oncology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.17 | 3.85 | 3.88 | ||
| High | 7.61 | 3.88 | 4.05 | ||
| Low | 7.12 | 3.77 | 3.73 | ||
| Last | 7.56 | 3.87 | 3.97 | ||
| Change | +0.31 | +0.01 | +0.17 | ||
| % Change | +4.28% | +0.26% | +4.47% | ||
| Volume | 113,600 | 197,200 | 750,900 | ||
| 20-Day Average Volume | 82,315 | 288,740 | 375,640 | ||
| Previous Close | 7.25 | 3.86 | 3.80 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.97 | 3.92 | 3.90 | ||
| 20-Day Raw Stochastic | 21.78% | 29.66% | 50.00% | ||
| 20-Day Relative Strength | 47.15% | 49.19% | 46.72% | ||
| Weighted Alpha | -53.80 | -17.02 | -14.58 | ||
| Today's Opinion | 24% Buy | 8% Buy | 8% Buy | ||
| Previous Opinion | 24% Buy | 8% Buy | 8% Sell | ||
| Last Month's Opinion | 64% Buy | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.82% since 06/03/24 | +0.78% since 06/03/24 | +5.59% since 06/03/24 | ||
| Low | 7.12 on 06/10/24 | 3.77 on 06/10/24 | 3.44 on 06/06/24 | ||
| High | 7.81 on 06/04/24 | 4.24 on 06/05/24 | 4.05 on 06/10/24 | ||
| 1-Month | |||||
| %Chg | -13.80% since 05/10/24 | +2.65% since 05/10/24 | -8.53% since 05/10/24 | ||
| Low | 7.12 on 06/10/24 | 3.65 on 05/13/24 | 3.44 on 06/06/24 | ||
| High | 9.14 on 05/20/24 | 4.38 on 05/15/24 | 4.50 on 05/15/24 | ||
| 3-Month | |||||
| %Chg | +52.73% since 03/08/24 | +6.91% since 03/08/24 | -29.48% since 03/08/24 | ||
| Low | 4.49 on 03/11/24 | 2.71 on 03/15/24 | 3.44 on 06/06/24 | ||
| High | 11.90 on 04/09/24 | 4.97 on 04/05/24 | 6.18 on 04/03/24 | ||
| 6-Month | |||||
| %Chg | +50.30% since 12/08/23 | +22.47% since 12/08/23 | +114.59% since 12/08/23 | ||
| Low | 3.19 on 02/13/24 | 2.71 on 03/15/24 | 1.64 on 12/22/23 | ||
| High | 11.90 on 04/09/24 | 4.97 on 04/05/24 | 6.85 on 02/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 223,858 | 229,338 | 223,774 | ||
| Shares Outstanding, K | 30,877 | 59,414 | 58,888 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -60,390,000 | -37,540,000 | -73,790,000 | ||
| Last Quarter Sales | 0 | 0 | 16,150,000 | ||
| Last Quarter Net Income | -16,490,000 | -8,080,000 | -3,260,000 | ||
| 60-Month Beta | 1.02 | 1.39 | 1.33 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/14/24 | -0.14 on 05/02/24 | -0.06 on 05/14/24 | ||
| Latest Earnings Date | 05/14/24 | 08/01/24 | 05/16/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||